Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

NCT02015351 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Choroidal Neovascularization

Interventions

DRUG: bevacizumab

Sponsor

University of Sao Paulo

Collaborators

[object Object]